View in EDS HTML Full Text PDF Full Text

Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study.

Saved in:
Bibliographic Details
Title: Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study.
Authors: Gilmore, Robert1,2 (AUTHOR), Fernandes, Richard1,2 (AUTHOR), Hartley, Imogen3 (AUTHOR), Arzivian, Arteen4 (AUTHOR), Leong, Rupert4 (AUTHOR), Andrew, Bridgette5 (AUTHOR), Vasudevan, Abhinav5,6 (AUTHOR), Greeve, Tessa7 (AUTHOR), Moore, Gregory Thomas7,8 (AUTHOR), Kim, Steven9 (AUTHOR), Lightowler, Daniel10,11 (AUTHOR), Singh, Abhey9,10 (AUTHOR), Mahy, Gillian12 (AUTHOR), Mithanthaya, Aditya13 (AUTHOR), Venugopaul, Kannan13 (AUTHOR), Han, Sangwoo14 (AUTHOR), Bryant, Robert14 (AUTHOR), West, Jack15 (AUTHOR), Segal, Jonathan15,16 (AUTHOR), Christensen, Britt15,16 (AUTHOR)
Source: Intestinal Research. Jul2025, Vol. 23 Issue 3, p347-357. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15989100
DOI:10.5217/ir.2024.00127